Bellerophon Therapeutics (BLPH) Short Interest Ratio & Short Volume

Short interest is the volume of Bellerophon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 66,800 shares of BLPH short. Learn More on Bellerophon Therapeutics' current short interest.

Bellerophon Therapeutics saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 66,800 shares, a decrease of 26.2% from the previous total of 90,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Bellerophon Therapeutics: Evelo Biosciences, Inc. (2.11%), SciSparc Ltd. (21.38%), Aditxt, Inc. (10.83%), China SXT Pharmaceuticals, Inc. (11.61%), Allarity Therapeutics, Inc. (24.95%), Biodexa Pharmaceuticals Plc (14.70%), Aptevo Therapeutics Inc. (9.10%), Sunshine Biopharma, Inc. (7.32%), Comera Life Sciences Holdings, Inc. (2.38%), GRI Bio, Inc. (0.61%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

Short selling BLPH is an investing strategy that aims to generate trading profit from Bellerophon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bellerophon Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLPH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLPH, twice per month. The most recent reporting period available is October, 15 2023.